Thorp Clay has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a purchase of 15000 shares of Clearside Biomedical, Inc. ($CLSDQ) on February 24, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2025 | Clearside Biomedical, Inc. | $CLSDQ | Thorp Clay | Not found | P | Common Stock | 15000 | $0.92 | 176,141.0000 | 0 | 9.31% | 0.00% |
| June 20, 2024 | Clearside Biomedical, Inc. | $CLSDQ | Thorp Clay | Not found | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Thorp Clay | Director | P | Common Stock | 10000 | $0.86 | 3,585,562.0000 | 0 | 0.28% | 0.00% |
| June 22, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Thorp Clay | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |